| ASSET | YEAR | % RETURN |
|---|---|---|
AXT (AXTI) | 2026 | 525.29% |
Lightwave Logic (LWLG) | 2026 | 414.46% |
MaxLinear (MXL) | 2026 | 358.1% |
Aehr Test Systems (AEHR) | 2026 | 333.82% |
Immunitybio (IBRX) | 2026 | 275.25% |
Ichor (ICHR) | 2026 | 253.15% |
Veradermics (MANE) | 2026 | 237.65% |
Ultra Clean (UCTT) | 2026 | 218.06% |
Fastly, Inc Class A Common Stock (FSLY) | 2026 | 213.26% |
Tango Therapeutics (TNGX) | 2026 | 173.45% |
Erasca (ERAS) | 2026 | 169.27% |
Enliven Therapeutics (ELVN) | 2026 | 168.26% |
Alumis (ALMS) | 2026 | 167.45% |
Amprius Technologies (AMPX) | 2026 | 153.25% |
Silicon Motion Technology (SIMO) | 2026 | 153.12% |
Babcock & Wilcox Enterprises (BW) | 2026 | 137.85% |
Chemours (CC) | 2026 | 135% |
Navitas Semiconductor (NVTS) | 2026 | 134% |
Day One Biopharmaceuticals (DAWN) | 2026 | 131.75% |
Almonty Industries Inc Common Shares (ALM) | 2026 | 128.13% |
Oruka Therapeutics (ORKA) | 2026 | 127.48% |
Iridium Communications (IRDM) | 2026 | 125.28% |
USA Rare Earth (USAR) | 2026 | 123.29% |
Diodes (DIOD) | 2026 | 122.9% |
Sasol (SSL) | 2026 | 119.85% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.